Risk Factors for Colonization with Multidrug-Resistant Bacteria among Patients Admitted to the Intensive Care Unit after Returning from Abroad

Journal of Travel Medicine

Volumn 22, Issue 5, 2015, Pages 300-305

  Angue, Marion ^a   Allou, Nicolas ^a   Belmonte, Olivier ^a   Lefort, Yannick ^a   Lugagne, Nathalie ^a   Vandroux, David ^a   Montravers, Philippe ^b   Allyn, Jérôme ^a,c  

^a CHR Felix Guyon   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; ISOPENICILLIN N; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PREVALENCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; TRAVEL; BACTERIAL COUNT; BACTERIAL INFECTIONS; FRANCE; INFECTION CONTROL; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FRANCE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TRAVEL;

EID: 84941191772     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12220     Document Type: Conference Paper

References (25)

1. European Antimicrobial Resistance Surveillance Network (EARS-Net). Antimicrobial Resistance Surveillance in Europe 2013. Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx. (Accessed 2014 Mar 21).
2. van der Bij AK, Pitout JD,. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012; 67: 2090-2100.
3. Kaiser AM, Schultsz C, Kruithof GJ, et al., Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands. Clin Microbiol Infect 2004; 10: 972-979.
4. Birgand G, Armand-Lefevre L, Lepainteur M, et al., Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country. Clin Microbiol Infect 2014; 20: 887-890.
5. Lepelletier D, Andremont A, Grandbastien B,. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Travel Med 2011; 18: 344-351.
6. Institut National de Santé Publique du Québec-Comité sur les infections nosocomiales du Québec. Avis et recommandations: Prévention et contrôle de la transmission des entérobactéries productrices de carbapénèmases dans les milieux de soins aigus du Québec, 2010. Available at: http://www.inspq.qc.ca/pdf/publications/1168-PreventionTransmissionEnterobactCarbapenemases.pdf (Accessed 2014 Mar 21).
7. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A,. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005; 33: 309-313.
8. Mattner F, Bange FC, Meyer E, et al., Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society for Hygiene and Microbiology. Dtsch Arztebl Int 2012; 109: 39-45.
9. Ostholm-Balkhed A, Tarnberg M, Nilsson M, et al., Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 2013; 68: 2144-2153.
10. Kennedy K, Collignon P,. Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010; 29: 1501-1506.
11. Barbe C, Fusellier A, Bureau Chalot F, et al., Predictive factors of acquisition of epidemic extended-spectrum beta-lactamase-producing Escherichia coli. Pathol Biol (Paris) 2010; 58: 25-28.
12. Société Française d'Hygiène Hospitalière. Prévention de la transmission croisée: précautions complémentaires contact, 2009. Available at: http://www.sf2h.net/publications-SF2H/SF2H-prevention-transmission-croisee-2009.pdf. (Accessed 2014 Mar 21).
13. Members of the SFM Antibiogram Committee. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21: 364-391.
14. Magiorakos AP, Srinivasan A, Carey RB, et al., Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-281.
15. Fankhauser C, Zingg W, Francois P, et al., Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly 2009; 139: 747-751.
16. Razazi K, Derde LP, Verachten M, et al., Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012; 38: 1769-1778.
17. Meyer E, Serr A, Schneider C, et al., Should we screen patients for extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units? Infect Control Hosp Epidemiol 2009; 30: 103-105.
18. Reddy P, Malczynski M, Obias A, et al., Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007; 45: 846-852.
19. Azim A, Dwivedi M, Rao PB, et al., Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria-an Indian experience. J Med Microbiol 2010; 59: 955-960.
20. Machado E, Coque TM, Canton R, et al., Leakage into Portuguese aquatic environments of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 2009; 63: 616-618.
21. Meunier D, Jouy E, Lazizzera C, et al., CTX-M-1- and CTX-M-15-type beta-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France. Int J Antimicrob Agents 2006; 28: 402-407.
22. Allyn J, Angue M, Belmonte O, et al., Delayed diagnosis of high drug-resistant microorganisms carriage in repatriated patients: three cases in a French intensive care unit. J Travel Med 2015; 22: 215-217.
23. Harris AD, Kotetishvili M, Shurland S, et al., How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 2007; 35: 97-101.
24. Birgand G, Armand-Lefevre L, Lolom I, et al., Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control 2013; 41: 443-447.
25. Hidalgo L, Hopkins KL, Gutierrez B, et al., Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK. J Antimicrob Chemother 2013; 68: 1543-1550.